首页 | 本学科首页   官方微博 | 高级检索  
检索        

万乃洛韦与阿昔洛韦治疗生殖器疱疹的成本-效果分析
引用本文:邱世犹,方敏华,潘光松.万乃洛韦与阿昔洛韦治疗生殖器疱疹的成本-效果分析[J].中国医院用药评价与分析,2003,3(3):167-168.
作者姓名:邱世犹  方敏华  潘光松
作者单位:广东省中山市古镇人民医院,中山市,528421
摘    要:目的 :比较万乃洛韦与阿昔洛韦治疗生殖器疱疹疗效及经济学成本。方法 :运用药物经济学原理对万乃洛韦和阿昔洛韦的成本 -效果进行最小成本比较分析。结果 :2种药物治疗生殖器疱疹的有效率分别为 92 86 %和 86 6 7% ,两者无显著性差异 (P>0 0 5 ) ,但费用的差别有统计学意义 ,阿昔洛韦费用较低。结论 :阿昔洛韦是治疗生殖器疱疹的首选药物。

关 键 词:万乃洛韦  阿昔洛韦  药物经济学  成本-效果分析  最小成本
文章编号:1672-2124(2003)03-167-02
修稿时间:2003年5月6日

Cost-effectiveness Analysis of Valaciclovir and Aciclovir in the Treatment of Genital Herpes
QIU Shiyou,FANG Minhua,PAN Guangsong.Cost-effectiveness Analysis of Valaciclovir and Aciclovir in the Treatment of Genital Herpes[J].Evaluation and Analysis of Drug-Use in Hospital of China,2003,3(3):167-168.
Authors:QIU Shiyou  FANG Minhua  PAN Guangsong
Abstract:OBJECTIVE:To compare the efficiency and economic cost between Valaciclovir and Aciclovir in the treatment of genital herpes. METHODS: To compare and analyze cost effectiveness analysis of Valaciclovir and Aciclovir in the treatment of genital herpes by pharmacoeconomic principle. RESULTS: the efficiency of these two drugs for genital herpes was 92.86% and 86.67% respectively. There was no obvious difference (\%P\%>0.05), but cost effectiveness analysis had statistical significance, cost of the latter was lower. CONCLUSION: Aciclovir is considered to be the first choice drug for genital herpes.
Keywords:Valaciclovir  Aciclovir  Pharmacoeconomics  cost  effectiveness analysis    
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号